Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01756144
Other study ID # 2012-005664-10
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 12, 2012
Last updated May 26, 2015
Start date July 2015
Est. completion date April 2016

Study information

Verified date May 2015
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority Belgium: Federal Agency for Medicinal Products and Health Products
Study type Interventional

Clinical Trial Summary

When there is a bone defect, bone transport is used to bridge the defect. Frequently, the bone in the docking site (where the transported bone comes together) doesn't heal.

The objective is to study the effectivity of rhBmp-2 (inductos) to stimulate bone healing, in order to find new techniques to treat non-union of long bones.

The method of the study is a randomized controlled trial, to compare rhBMP-2 and autologous bone grafting in stimulating bone healing in the docking site.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date April 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients treated with bone transport (Ilizarov technique) and have non-union of the docking site, which is characterized by absence of bridging callus after two months of compression in the docking site.

Exclusion Criteria:

- Allergy for inductos

- active growth,

- malignancy

- infection

- PAD

- pathological fracture

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
rhBMP-2


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Outcome

Type Measure Description Time frame Safety issue
Primary Bone healing in the docking site up to 4 months No
Secondary Infection up to one year Yes
Secondary Edema up to one year Yes
Secondary cancer up to one year Yes
See also
  Status Clinical Trial Phase
Recruiting NCT03970941 - Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Terminated NCT00424567 - Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. Phase 1/Phase 2
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Completed NCT00916981 - Treatment of Atrophic Nonunion by Preosteoblast Cells Phase 1/Phase 2
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Enrolling by invitation NCT06103396 - Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) Phase 1/Phase 2
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System